|Human papillomavirus and survival of patients with oropharyngeal cancer|
KK Ang, J Harris, R Wheeler, R Weber, DI Rosenthal, PF Nguyen-Tân, ...
New England Journal of Medicine 363 (1), 24-35, 2010
|Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1, 3-galactose|
CH Chung, B Mirakhur, E Chan, QT Le, J Berlin, M Morse, BA Murphy, ...
New England journal of medicine 358 (11), 1109-1117, 2008
|PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma|
MR Migden, D Rischin, CD Schmults, A Guminski, A Hauschild, KD Lewis, ...
New England Journal of Medicine 379 (4), 341-351, 2018
|Chromosomal instability drives metastasis through a cytosolic DNA response|
SF Bakhoum, B Ngo, AM Laughney, JA Cavallo, CJ Murphy, P Ly, P Shah, ...
Nature 553 (7689), 467-472, 2018
|Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression|
CH Chung, JS Parker, G Karaca, J Wu, WK Funkhouser, D Moore, ...
Cancer cell 5 (5), 489-500, 2004
|Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas|
CH Chung, K Ely, L McGavran, M Varella-Garcia, J Parker, N Parker, ...
Journal of clinical oncology 24 (25), 4170-4176, 2006
|Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer|
ML Gillison, Q Zhang, R Jordan, W Xiao, WH Westra, A Trotti, S Spencer, ...
Journal of clinical oncology 30 (17), 2102, 2012
|Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications|
CH Chung, ML Gillison
Clinical cancer research 15 (22), 6758-6762, 2009
|Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas|
Y Wang, S Springer, CL Mulvey, N Silliman, J Schaefer, M Sausen, ...
Science translational medicine 7 (293), 293ra104-293ra104, 2015
|Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy …|
PF Nguyen-Tan, Q Zhang, KK Ang, RS Weber, DI Rosenthal, D Soulieres, ...
Journal of Clinical Oncology 32 (34), 3858, 2014
|E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of …|
S Marur, S Li, AJ Cmelak, ML Gillison, WJ Zhao, RL Ferris, WH Westra, ...
Journal of Clinical Oncology 35 (5), 490, 2017
|p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma|
CH Chung, Q Zhang, CS Kong, J Harris, EJ Fertig, PM Harari, D Wang, ...
Journal of clinical oncology 32 (35), 3930, 2014
|Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma|
RJC Slebos, Y Yi, K Ely, J Carter, A Evjen, X Zhang, Y Shyr, BM Murphy, ...
Clinical cancer research 12 (3), 701-709, 2006
|Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials|
A Drilon, S Siena, R Dziadziuszko, F Barlesi, MG Krebs, AT Shaw, ...
The Lancet Oncology 21 (2), 261-270, 2020
|Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the mayo clinic phase 2 consortium (NCI-9742)|
BBY Ma, WT Lim, BC Goh, EP Hui, KW Lo, A Pettinger, NR Foster, ...
Journal of Clinical Oncology 36 (14), 1412, 2018
|lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling|
Y Lu, X Zhao, Q Liu, C Li, R Graves-Deal, Z Cao, B Singh, JL Franklin, ...
Nature medicine 23 (11), 1331-1341, 2017
|Molecular portraits and the family tree of cancer|
CH Chung, PS Bernard, CM Perou
Nature genetics 32 (4), 533-540, 2002
|Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-κB signaling as characteristics of a high-risk head and neck squamous …|
CH Chung, JS Parker, K Ely, J Carter, Y Yi, BA Murphy, KK Ang, ...
Cancer research 66 (16), 8210-8218, 2006
|Emerging biomarkers in head and neck cancer in the era of genomics|
H Kang, A Kiess, CH Chung
Nature reviews Clinical oncology 12 (1), 11-26, 2015
|Managing premedications and the risk for reactions to infusional monoclonal antibody therapy|
The oncologist 13 (6), 725-732, 2008